Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 7876 to 7890 of 8911 results

  1. Into practice guide (PMG30)

    This guide has been updated and replaced by practical steps to improving the quality of care and services using NICE guidance.

    Withdrawn guide

  2. Health technology evaluations: interim methods and process guide for the proportionate approach to technology appraisals (PMG40)

    This interim methods and process guide for the proportionate approach to technology appraisals has been incorporated into NICE health technology evaluations: the manual.

    Withdrawn guide

  3. Medical technologies evaluation programme process guide (PMG34)

    This medical technologies evaluation programme process guide has been replaced by the NICE HealthTech programme manual.

    Withdrawn guide

  4. Key therapeutic topics – Medicines management options for local implementation: Interim process statement (PMG7)

    February 2022: we have withdrawn our medicines optimisation: key therapeutic topics. We have taken this decision after reviewing the wide range of services we currently provide, so we can focus on delivering the priorities outlined in our 5-year strategy. If you have any queries, please contact nice@nice.org.uk.

    Withdrawn guide

  5. Canagliflozin for treating type 2 diabetes in people 10 to 17 years [ID6352]

    In development Reference number: GID-TA11377 Expected publication date: TBC

    Technology appraisal guidance
    In development

  6. Diabetes: statins for primary prevention of CVD (T2DM and 10% risk) (IND182)

    This guidance has been updated and replaced by NICE indicator 274.

    Withdrawn indicator

  7. Atrial fibrillation: pulse rhythm assessment in people at risk (IND168)

    This indicator has been withdrawn following National Screening Committee recommendations and ongoing research.

    Withdrawn indicator

  8. Weight management: BMI calculation in preceding 5 years (IND167)

    This indicator has been withdrawn following discussions with the National Screening Committee.

    Withdrawn indicator

  9. Diabetes: T1DM and statins (IND166)

    This guidance has been updated and replaced by NICE indicator 277.

    Withdrawn indicator

  10. Cardiovascular disease prevention: statins for people newly diagnosed with hypertension or T2DM (IND162)

    This indicator has been updated and replaced by NICE indicator 287.

    Withdrawn indicator

  11. Weight management: BMI recording (long-term conditions) (IND151)

    This indicator has been updated and replaced by NICE indicator 320.

    Withdrawn indicator

  12. Diabetes: blood pressure (without moderate or severe frailty) (IND236)

    This indicator has been updated and replaced by NICE indicator 249.

    Withdrawn indicator

  13. Diabetes: annual psychological assessment (children) (IND57)

    This indicator has been updated and replaced by NICE indicator 313 and NICE indicator 314.

    Withdrawn indicator

  14. Diabetes: thyroid disease screening (children) (IND56)

    This indicator has been updated and replaced by NICE indicator 312.

    Withdrawn indicator

  15. Diabetes: annual smoking status (children) (IND55)

    This indicator has been updated and replaced by NICE indicator 310 and NICE indicator 311.

    Withdrawn indicator